Yi-chao Zheng

100 Kexue Avenue
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Corrigendum to "A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric Cancer" [Bioorg. Chem. 180 (2026) 110067].

Corrigendum to "A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric Cancer" [Bioorg. Chem. 180 (2026) 110067].

Journal: Bioorganic chemistry

Published: August 12, 2026

Pharmacological inhibition of LSD1 suppresses the CD155/TIGIT immune checkpoint axis and enhances NK cell-mediated cytotoxicity in colorectal cancer.

Pharmacological inhibition of LSD1 suppresses the CD155/TIGIT immune checkpoint axis and enhances NK cell-mediated cytotoxicity in colorectal cancer.

Journal: Bioorganic chemistry

Published: June 28, 2026

Targeting antibody-inaccessible immune resistance with small-molecule immunotherapy.

Targeting antibody-inaccessible immune resistance with small-molecule immunotherapy.

Journal: International immunopharmacology

Published: June 05, 2026

A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric Cancer.

A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric Cancer.

Journal: Bioorganic chemistry

Published: April 01, 2026

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy.

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy.

Journal: Theranostics

Published: January 03, 2026

Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery.

Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery.

Journal: Medicinal research reviews

Published: December 03, 2025

Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation.

Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation.

Journal: Journal of medicinal chemistry

Published: October 29, 2025

Multiple gastric cancer tissue proteomic identification predicts CLU as a biomarker for anti-PD-1 immunotherapy.

Multiple gastric cancer tissue proteomic identification predicts CLU as a biomarker for anti-PD-1 immunotherapy.

Journal: Journal of pharmaceutical analysis

Published: September 07, 2025

Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics.

Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics.

Journal: Cancers

Published: July 05, 2025

The Exploration of Indole-Based LSD1-Targeted Inhibitors for Enhanced Immune Response in Gastric Cancer via the PD-L1/PD-1 Axis.

The Exploration of Indole-Based LSD1-Targeted Inhibitors for Enhanced Immune Response in Gastric Cancer via the PD-L1/PD-1 Axis.

Journal: Journal of medicinal chemistry

Published: April 21, 2025

Comparative analysis for optimal LSD1 inhibitors evaluation techniques: pros and cons.

Comparative analysis for optimal LSD1 inhibitors evaluation techniques: pros and cons.

Journal: Journal of pharmaceutical analysis

Published: April 20, 2025

LSD1 engaged ERα activation orchestrates the formation of migrasomes to promote gastric cancer metastasis.

LSD1 engaged ERα activation orchestrates the formation of migrasomes to promote gastric cancer metastasis.

Journal: International journal of biological macromolecules

Published: February 25, 2025

Showing 1-12 of 81

Last Updated: 09/26/2026